About company

MedPacto is an innovative drug discovery and development company based in South Korea that delivers therapeutics targeting cancer and autoimmune diseases. Our expertise lies in utilizing genome-based methods to identify novel targets and to develop first-in-class and best-in-class drugs.

KR
Unknown
Not verified company